Keyword: InFLAMES Flagship

This page displays contents related to the keyword.

InFLAMES Corporate Corner delves into the possibilities of novel techniques in medical research

28.04.2023

New technologies aim to find revolutionary ways to diagnose, treat and prevent diseases. The second InFLAMES Flagship Corporate Corner of 2023 will focus on the topic from the perspectives of both researchers and companies.  The InFLAMES Corporate Corner will take place on 11th May from 12 to 16 at the Visitor and Innovation Centre Joki in Turku. The event is open to all.

Promising Results from a Nasal Pertussis Vaccine Against Whooping Cough

24.04.2023

A new nasal pertussis vaccine against whooping cough has shown promising results. The vaccine was shown to be safe and to work against whooping cough in a study conducted in healthy adults. Professor Qiushui He and Project Researcher Alex-Mikael Barkoff from the InFLAMES research flagship of the University of Turku participated in the study. The research article was published in the esteemed medical journal Lancet.

InFLAMES Corporate Corner – Novel Technologies to Improve Human Health

Time

11.5.2023 at 11.45 - 16.00
Welcome to the InFLAMES Research Flagship’s Corporate Corner titled Novel Technologies to Improve Human Health. All interested parties are welcome. We have a great list of speakers from InFLAMES, Finnish Red Cross Blood Service, Brinter, Finnadvance and there’s more to come! The event starts with...

CRISPR workshop

Time

13.3.2023 at 9.00 - 17.3.2023 at 12.00
Program: 13.3. 9:00 - 11:00 Theoretical background,assigning working groups 14.3. 9:00 - 12:00 RNP assembly and nucleofection 17.3. 9:00 - 12:00 Cell harvest and flow cytometry, data analysis

Research Project on the Development of Human Immune System in Early Life Obtains Multimillion Funding

01.12.2022

The first few months and years of life are crucial to the development of the human immune system. This is an important phase as the immune system can define which diseases individuals might develop later in life. INITIALISE, a joint research project of ten universities, will study which environmental factors and mechanisms modify the human immune system in early life and whether targeted interventions could have a positive impact. The project obtained nearly seven million in funding from Horizon Europe.